RET and multiple endocrine neoplasia type 2: For example, in genetic testing for multiple endocrine neoplasia type 2 (MEN2), it refers to the risks and benefits resulting from genetic test use, in which RET mutation testing provides a means to identify individuals who would benefit from preventive surgery [312].